Erydel series B financing

Erydel, the drug delivery company specialised in delivery through autologous red blood cells, completed a €15m series B financing led by Genextra S.p.A., with existing investors Innogest SGR and Focus Gestioni SGR also participating. Torch Partners acted as exclusive financial advisor to Erydel on the financing.

URL: 

http://www.erydel.com/

Investors

Genextra S.p.A, Innogest SGR and Focus Gestioni SGR

Product

Financings

€15,000,000 Series B
Fund raising
July 2013